Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.60 |
| ▸ | PPARA | Q07869 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | HSD11B1 | P28845 | 3/20 | 0.47 |
| ▸ | HSD11B2 | P80365 | 3/20 | 0.47 |
| ▸ | CNR1 | P21554 | 1/20 | 0.47 |
| ▸ | PPARG | P37231 | 4/20 | 0.46 |
| ▸ | FABP2 | P12104 | 1/20 | 0.46 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.46 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29195871 | 0.98 | ALDH1A1 (0.58) | ALDH1A1KDM4EHSD17B10PPARAMAPT | |
| SCHEMBL5822903 | 0.86 | ALDH1A1 (0.57) | ALDH1A1KDM4EHSD17B10PPARAMAPT | |
| SCHEMBL12301773 | 0.85 | HSD11B1 (0.44) | ALDH1A1KDM4EHSD17B10MAPTMEN1 | |
| SCHEMBL9589205 | 0.85 | HSD11B1 (0.47) | ALDH1A1KDM4EHSD17B10MAPTMEN1 | |
| SCHEMBL11939834 | 0.84 | ALDH1A1 (0.55) | ALDH1A1KDM4EHSD17B10PPARAMAPT | |
| SCHEMBL2014944 | 0.84 | ALDH1A1 (0.43) | ALDH1A1KDM4EHSD17B10PPARAMAPT | |
| SCHEMBL4247858 | 0.84 | HSD11B1 (0.44) | ALDH1A1KDM4EHSD17B10MAPTMEN1 | |
| SCHEMBL28093019 | 0.81 | TDP1 (0.47) | ALDH1A1KDM4EHSD17B10PPARAMAPT | |
| SCHEMBL8042027 | 0.80 | HSD11B1 (0.50) | ALDH1A1PPARAMAPTMEN1CYP1A2 | |
| SCHEMBL6544670 | 0.80 | L3MBTL1 (0.67) | ALDH1A1KDM4EHSD17B10MAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4121402-B1 | METHOD OF FORMING FERTILIZER COMPOSITIONS HAVING SLOW-RELEASE NITROGEN COMPOUNDS | OMS INVEST INC (US) | 2026-05-06 | — | — | EP | claimed |
| EP-3229589-B1 | UREA FERTILIZER COMPOSITIONS COMPRISING RICE HULLS AND METHODS OF USE | OMS INVEST INC (US) | 2025-02-05 | — | — | EP | claimed |
| CN-116322323-A | Water-soluble concentrate compositions | 罗地亚经营管理公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4121402-A1 | FERTILIZER COMPOSITIONS HAVING SLOW-RELEASE NITROGEN COMPOUNDS AND METHODS OF FORMING THEREOF | OMS Investments, Inc. (US) | 2023-01-25 | — | — | EP | claimed |
| US-20210292256-A1 | UREA FERTILIZER COMPOSITIONS COMPRISING RICE HULLS AND METHODS OF USE | JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT | 2021-09-23 | — | — | US | claimed |
| WO-2021189014-A1 | FERTILIZER COMPOSITIONS HAVING SLOW-RELEASE NITROGEN COMPOUNDS AND METHODS OF FORMING THEREOF | OMS INVESTMENTS, INC. (US) | 2021-09-23 | — | — | WO | claimed |
| EP-3731618-A1 | COMPOSITIONS AND METHODS FOR CONTROLLING PLANT OR CROP SIZE IN A CONTROLLED ENVIRONMENT | BASF Agricultural Solutions Seed US LLC (US) | 2020-11-04 | — | — | EP | claimed |
| CN-211837872-U | Temperature-adjustable p-chlorophenoxyisobutyric acid preparation reaction kettle | 常州市天华制药有限公司 | 2020-11-03 | — | — | CN | claimed |
| US-10822290-B2 | Urea fertilizer compositions comprising rice hulls and methods of use | OMS INVESTMENTS, INC. (US) | 2020-11-03 | — | — | US | claimed |
| EP-3156708-B1 | TUBING ASSEMBLY | REHAU AG & CO (DE) | 2020-03-04 | — | — | EP | claimed |
| EP-1217884-B1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2007-02-21 | — | — | EP | claimed |
| EP-1372571-A4 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS (US) | 2006-06-07 | — | — | EP | claimed |
| US-6897065-B1 | Method for maturation of conifer somatic embryos | WOODY PLANT BIOTECH APS (DK) | 2005-05-24 | — | — | US | claimed |
| EP-1372571-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | New Century Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | NEW CENTURY PHARMACEUTICALS, INC. | 2002-12-19 | — | — | US | claimed |
| WO-2002074246-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1217884-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | Woody Plant Biotech APS (DK) | 2002-07-03 | — | — | EP | claimed |
| US-20020004458-A1 | Methods for inducing production of isoflavone levels in plants using nuclear receptor ligands | GRAHAM TERRENCE L (US) | 2002-01-10 | — | — | US | claimed |
| WO-2001058262-A1 | METHODS OF INDUCING PRODUCTION OF ISOFLAVONES IN PLANTS USING NUCLEAR RECEPTOR LIGANDS | THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2001-08-16 | — | — | WO | claimed |
| WO-2001020972-A1 | METHOD FOR MATURATION OF CONIFER SOMATIC EMBRYOS | WOODY PLANT BIOTECH APS (DK) | 2001-03-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004458-A1 | Methods for inducing production of isoflavone levels in plants using nuclear receptor ligands | GPER1, NR1H2, NR1H3 | ALDH1A1 4534/4885KDM4E 4190/4885HSD17B10 370/4885 |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | ALB, TYMP, SHBG | ALDH1A1 2784/4885KDM4E 3521/4885HSD17B10 2380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.